Retigabine (exempt preparation)

Retigabine (exempt preparation) (Cay-40314) is an analytical reference standard categorized as a positive allosteric modulator (PAM) of KCNQ2-5 (Kv7.2-7.5) potassium ion channels. Formulations containing retigabine have been used in the treatment of partial epilepsies. Retigabine is regulated as a Schedule V compound in the United States. Retigabine (exempt preparation) (Cay-40314) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.Formal Name: N-[2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]-carbamic acid, ethyl ester. CAS Number: 150812-12-7. Molecular Formula: C16H18FN3O2. Formula Weight: 303.3. Purity: >98%. Formulation: (Request formulation change), A 1 mg/ml solution in acetonitrile. lambdamax: 221, 254, 305 nm. SMILES: O=C(OCC)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1. InChi Code: InChI=1S/C16H18FN3O2/c1-2-22-16(21)20-15-8-7-13(9-14(15)18)19-10-11-3-5-12(17)6-4-11/h3-9,19H,2,10,18H2,1H3,(H,20,21). InChi Key: PCOBBVZJEWWZFR-UHFFFAOYSA-N.